Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
LETTER TO THE EDITOR
Full Access
full
Veterinary oncologists adapting to COVID-19 pandemic
- Page: 257
- First Published: 30 March 2020
ORIGINAL ARTICLES
Full Access
full
Evaluation of a 0.75 × 109/L absolute neutrophil count cut-off for antimicrobial prophylaxis in canine cancer chemotherapy patients
- Pages: 258-268
- First Published: 10 October 2019
Full Access
full
Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence
- Pages: 269-280
- First Published: 16 October 2019
Full Access
full
Microtomographic characterization of calcifications in canine mammary tumours
- Pages: 281-291
- First Published: 12 October 2019
Full Access
full
Preliminary assessment of serum clusterin as a potential biomarker for canine lymphoma
- Pages: 292-302
- First Published: 26 October 2019
Full Access
full
Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours
- Pages: 303-314
- First Published: 25 October 2019
Full Access
full
Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches
- Pages: 315-323
- First Published: 30 October 2019
Full Access
full
A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma
- Pages: 324-341
- First Published: 29 October 2019
Full Access
full
Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol
- Pages: 342-352
- First Published: 04 November 2019
Full Access
full
Aberrantly expressed snoRNA, snRNA, piRNA and tRFs in canine melanoma
- Pages: 353-361
- First Published: 26 November 2019
Full Access
full
Toxicity and outcome in cats with oral squamous cell carcinoma after accelerated hypofractionated radiotherapy and concurrent systemic treatment
- Pages: 362-369
- First Published: 22 November 2019
Full Access
full
Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations
- Pages: 370-380
- First Published: 21 November 2019
Full Access
full
Definitive-intent intensity-modulated radiation therapy for treatment of canine prostatic carcinoma: A multi-institutional retrospective study
- Pages: 381-388
- First Published: 07 December 2019
Full Access
full
Ultrasound is a poor predictor of early or overt liver or spleen metastasis in dogs with high-risk mast cell tumours
- Pages: 389-401
- First Published: 20 December 2019
Full Access
full
Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours
- Pages: 402-408
- First Published: 09 January 2020
Full Access
full
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery
- Pages: 409-415
- First Published: 12 January 2020
Full Access
full
Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4−CD8− by flow cytometry
- Pages: 416-427
- First Published: 17 January 2020
SHORT COMMUNICATIONS
Full Access
full
Electrochemotherapy in treatment of canine oral non-tonsillar squamous cell carcinoma. A case series report
- Pages: 428-432
- First Published: 16 August 2019
Full Access
full
Investigation of thyroid function in dogs treated with the tyrosine kinase inhibitor toceranib
- Pages: 433-437
- First Published: 09 September 2019
Full Access
full
Mutation and methylation status of KIT and TP53 in canine cutaneous and subcutaneous mast cell tumours
- Pages: 438-444
- First Published: 01 October 2019